4.03MMarket Cap-22P/E (TTM)
0.4874High0.4131Low1.46MVolume0.4500Open0.4804Pre Close699.62KTurnover18.06%Turnover RatioLossP/E (Static)9.37MShares16.748052wk High1.25P/B3.48MFloat Cap0.284052wk Low--Dividend TTM8.08MShs Float103.0000Historical High--Div YieldTTM15.47%Amplitude0.2840Historical Low0.4790Avg Price1Lot Size
Cingulate Stock Forum
Cingulate Achieves Key Manufacturing Milestone in the Development of Its Adhd Drug Ctx-1301 in Preparation for FDA Marketing Clearance
NEWS
FDA Clears Cingulate to File for Marketing Approval of Ctx-1301 in the Treatment of Adhd
No comment yet